Evaluation of Immunohistochemical Markers of Lymphatic and Blood Vessels in Canine Mammary Tumours

Journal of Comparative Pathology

Volumn 148, Issue 4, 2013, Pages 307-317

  Sleeckx, N ^a   Van Brantegem, L ^b   Fransen, E ^a   Van den Eynden, G ^c   Casteleyn, C ^a   Veldhuis Kroeze, E ^d   Van Ginneken, C ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c GZA Hospitals St   (Belgium)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Blood vessel; Canine mammary tumour; Immunohistochemistry; Lymphatic vessel

Indexed keywords

BIOLOGICAL MARKER; CD31 ANTIGEN; CD34 ANTIBODY; LYVE 1 PROTEIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY D2-40; PODOPLANIN; PROX 1 PROTEIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BENIGN TUMOR; BLOOD VESSEL; BREAST TUMOR; CONTROLLED STUDY; DOG; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH VESSEL; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; TISSUE SECTION;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BIOLOGICAL MARKERS; BLOOD VESSELS; DOG DISEASES; DOGS; FEMALE; HOMEODOMAIN PROTEINS; LYMPHATIC VESSELS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MEMBRANE GLYCOPROTEINS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR SUPPRESSOR PROTEINS; VESICULAR TRANSPORT PROTEINS;

ANIMALIA; CANIDAE; CANIS FAMILIARIS;

EID: 84876805729     PISSN: 00219975     EISSN: 15323129     Source Type: Journal    
DOI: 10.1016/j.jcpa.2012.09.007     Document Type: Article

References (52)

1. Al-Rawi M.A., Mansel R.E., Jiang W.G. Lymphangiogenesis and its role in cancer. Histology and Histopathology 2005, 20:283-298.
2. Baluk P., McDonald D.M. Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Annals of the New York Academy of Science 2008, 1131:1-12.
3. Clemente M., Perez-Alenza M.D., Illera J.C., Pena L. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer. Veterinary Pathology 2010, 47:265-274.
4. Duff S.E., Jeziorska M., Kumar S., Haboubi N., Sherlock D., et al. Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer. Colorectal Disease 2007, 9:793-800.
5. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? GHA Clowes Memorial Award Lecture. Cancer Research 1986, 46:467-473.
6. Fox S.B., Gatter K.C., Harris A.L. Tumour angiogenesis. Journal of Pathology 1996, 179:232-237.
7. Galeotti F., Barzagli F., Vercelli A., Millanta F., Poli A., et al. Feline lymphangiosarcoma - definitive identification using a lymphatic vascular marker. Veterinary Dermatology 2004, 15:13-18.
8. Gillespie V., Baer K., Farrelly J., Craft D., Luong R. Canine gastrointestinal stromal tumors: immunohistochemical expression of CD34 and examination of prognostic indicators including proliferation markers Ki67 and AgNOR. Veterinary Pathology 2011, 48:283-291.
9. Gordon I.K., Khanna C. Modeling opportunities in comparative oncology for drug development. ILAR Journal 2010, 51:214-220.
10. Graham J.C., Myers R.K. The prognostic significance of angiogenesis in canine mammary tumors. Journal of Veterinary Internal Medicine 1999, 13:416-418.
11. Griffey S.M., Verstraete F.J., Kraegel S.A., Lucroy M.D., Madewell B.R. Computer-assisted image analysis of intratumoral vessel density in mammary tumors from dogs. American Journal of Veterinary Research 1998, 59:1238-1242.
12. Guidi A.J., Berry D.A., Broadwater G., Perloff M., Norton L., et al. Association of angiogenesis in lymph node metastases with outcome of breast cancer. Journal of the National Cancer Institute 2000, 92:486-492.
13. Hansen S., Grabau D.A., Rose C., Bak M., Sorensen F.B. Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Laboratory Investigation 1998, 78:1563-1573.
14. Holopainen T., Bry M., Alitalo K., Saaristo A. Perspectives on lymphangiogenesis and angiogenesis in cancer. Journal of Surgical Oncology 2011, 103:484-488.
15. Johnson L.A., Prevo R., Clasper S., Jackson D.G. Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. Journal of Biological Chemistry 2007, 282:33671-33680.
16. Junginger J., Rotting A., Staszyk C., Kramer K., Hewicker-Trautwein M. Identification of equine cutaneous lymphangioma by application of a lymphatic endothelial cell marker. Journal of Comparative Pathology 2010, 143:57-60.
17. Khanna C., Hunter K. Modeling metastasis in vivo. Carcinogenesis 2005, 26:513-523.
18. Klopfleisch R., von Euler H., Sarli G., Pinho S.S., Gartner F., et al. Molecular carcinogenesis of canine mammary tumors: news from an old disease. Veterinary Pathology 2011, 48:98-116.
19. Lavalle G.E., Bertagnolli A.C., Tavares W.L., Cassali G.D. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival. Veterinary Pathology 2009, 46:1275-1280.
20. Luong R.H., Baer K.E., Craft D.M., Ettinger S.N., Scase T.J., et al. Prognostic significance of intratumoral microvessel density in canine soft-tissue sarcomas. Veterinary Pathology 2006, 43:622-631.
21. MacEwen E.G., Withrow S.J. Tumors of the mammary gland. Small Animal Clinical Oncology 1996, 356-372. WB Saunders Company, Philadelphia. 2nd Edit. S.J. Withrow, E.G. MacEwen (Eds.).
22. Maiolino P., Papparella S., Restucci B., De Vico G. Angiogenesis in squamous cell carcinomas of canine skin: an immunohistochemical and quantitative analysis. Journal of Comparative Pathology 2001, 125:117-121.
23. Martano M., Maiolino P., Cataldi M., Restucci B. Evaluation of angiogenesis by morphometric analysis of blood vessels in dysplastic and neoplastic lesions of canine gingiva. Veterinary Research Communications 2004, 28(Suppl. 1):299-301.
24. Martin A., Gasse H., Staszyk C. Absence of lymphatic vessels in the dog dental pulp: an immunohistochemical study. Journal of Anatomy 2010, 217:609-615.
25. Misdorp W., Else R.W., Hellmén E., Lipscomb T.P. Histological Classification of Mammary Tumors of the Dog and the Cat 1999, Armed Forces Institute of Pathology, American Registry of Pathology and World Health Organisation Collaborating Center for Worldwide Reference on Comparative Oncology, Washington DC, pp. 59.
26. Porrello A., Cardelli P., Spugnini E.P. Oncology of companion animals as a model for humans. an overview of tumor histotypes. Journal of Experimental and Clinical Cancer Research 2006, 25:97-105.
27. Preziosi R., Sarli G., Paltrinieri M. Prognostic value of intratumoral vessel density in cutaneous mast cell tumors of the dog. Journal of Comparative Pathology 2004, 130:143-151.
28. Queiroga F.L., Raposo T., Carvalho M.I., Prada J., Pires I. Canine mammary tumours as a model to study human breast cancer: most recent findings. In Vivo 2011, 25:455-465.
29. Reis-Filho J.S., Schmitt F.C. Lymphangiogenesis in tumors: what do we know?. Microscopic Research and Technique 2003, 60:171-180.
30. Restucci B., De Vico G., Maiolino P. Evaluation of angiogenesis in canine mammary tumors by quantitative platelet endothelial cell adhesion molecule immunohistochemistry. Veterinary Pathology 2000, 37:297-301.
31. Restucci B., Maiolino P., Paciello O., Martano M., De Vico G., et al. Evaluation of angiogenesis in canine seminomas by quantitative immunohistochemistry. Journal of Comparative Pathology 2003, 128:252-259.
32. Saaristo A., Karpanen T., Alitalo K. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene 2000, 19:6122-6129.
33. Saito Y., Nakagami H., Morishita R., Takami Y., Kikuchi Y., et al. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. Circulation 2006, 114:1177-1184.
34. Sarli G., Sassi F., Brunetti B., Rizzo A., Diracca L., et al. Lymphatic vessels assessment in feline mammary tumours. BMC Cancer 2007, 7:7.
35. Schacht V., Dadras S.S., Johnson L.A., Jackson D.G., Hong Y.K., et al. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. American Journal of Pathology 2005, 166:913-921.
36. Sleeckx N., de Rooster H., Veldhuis Kroeze E.J., Van Ginneken C., Van Brantegem L. Canine mammary tumours, an overview. Reproduction in Domestic Animals 2011, 46:1112-1131.
37. Sleeman J., Schmid A., Thiele W. Tumor lymphatics. Seminars in Cancer Biology 2009, 19:285-297.
38. Staszyk C., Duesterdieck K.F., Gasse H., Bienert A. Immunohistochemical identification of lymphatic vessels in the periodontium of equine cheek teeth. Journal of Veterinary Dentistry 2005, 22:227-232.
39. Sugiyama A., Takeuchi T., Morita T., Okamura Y., Minami S., et al. Lymphangiosarcoma in a cat. Journal of Comparative Pathology 2007, 137:174-178.
40. Tonar Z., Egger G.F., Witter K., Wolfesberger B. Quantification of microvessels in canine lymph nodes. Microscopic Research and Technique 2008, 71:760-772.
41. Uva P., Aurisicchio L., Watters J., Loboda A., Kulkarni A., et al. Comparative expression pathway analysis of human and canine mammary tumors. BMC Genomics 2009, 10:135.
42. Uzzan B., Nicolas P., Cucherat M., Perret G.Y. Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Research 2004, 64:2941-2955.
43. Van den Eynden G.G., Van der Auwera I., Van Laere S.J., Colpaert C.G., van Dam P., et al. Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study. British Journal of Cancer 2006, 94:1643-1649.
44. Van der Auwera I., Cao Y., Tille J.C., Pepper M.S., Jackson D.G., et al. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. British Journal of Cancer 2006, 95:1611-1625.
45. Van der Auwera I., Van den Eynden G.G., Colpaert C.G., Van Laere S.J., van Dam P., et al. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Clinical Cancer Research 2005, 11:7637-7642.
46. Van der Auwera I., Van Laere S.J., Van den Eynden G.G., Benoy I., van Dam P., et al. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clinical Cancer Research 2004, 10:7965-7971.
47. Vermeulen P.B., Gasparini G., Fox S.B., Colpaert C., Marson L.P., et al. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. European Journal of Cancer 2002, 38:1564-1579.
48. Vermeulen P.B., Gasparini G., Fox S.B., Toi M., Martin L., et al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. European Journal of Cancer 1996, 32A:2474-2484.
49. Vleugel M.M., Bos R., van der Groep P., Greijer A.E., Shvarts A., et al. Lack of lymphangiogenesis during breast carcinogenesis. Journal of Clinical Pathology 2004, 57:746-751.
50. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. New England Journal of Medicine 1991, 324:1-8.
51. Williams C.S., Leek R.D., Robson A.M., Banerji S., Prevo R., et al. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. Journal of Pathology 2003, 200:195-206.
52. Wolfesberger B., Tonar Z., Witter K., Guija de Arespacohaga A., Skalicky M., et al. Microvessel density in normal lymph nodes and lymphomas of dogs and their correlation with vascular endothelial growth factor expression. Research in Veterinary Science 2008, 85:56-61.